Garcia-Martínez, I
Sánchez-Mora, C
Pagerols, M
Richarte, V
Corrales, M
Fadeuilhe, C
Cormand, B
Casas, M
Ramos-Quiroga, J A
Ribasés, M
Article History
Received: 2 December 2015
Revised: 16 June 2016
Accepted: 19 June 2016
First Online: 30 August 2016
Competing interests
: MC has received travel grants and research support from Eli Lilly, Janssen-Cilag, Shire and Laboratorios Rubió. He has been on the advisory board and served as a consultant for Eli Lilly, Janssen-Cilag, Shire and Laboratorios Rubió.JAR-Q has served on the speakers' bureau and acted as consultant for Eli Lilly, Janssen-Cilag, Novartis, Lundbeck, Shire, Ferrer and Laboratorios Rubió. He has received travel awards from Eli Lilly, Janssen-Cilag and Shire for participating in psychiatric meetings. The ADHD Program chaired by JAR-Q has received unrestricted educational and research support from Eli Lilly, Janssen-Cilag, Shire, Rovi and Laboratorios Rubió in the past 2 years. The remaining authors declare no conflict of interest.